Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 Apr 2024
Historique:
received: 29 08 2023
accepted: 03 04 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: epublish

Résumé

Under-reporting of COVID-19 and the limited information about circulating SARS-CoV-2 variants remain major challenges for many African countries. We analyzed SARS-CoV-2 infection dynamics in Addis Ababa and Jimma, Ethiopia, focusing on reinfection, immunity, and vaccination effects. We conducted an antibody serology study spanning August 2020 to July 2022 with five rounds of data collection across a population of 4723, sequenced PCR-test positive samples, used available test positivity rates, and constructed two mathematical models integrating this data. A multivariant model explores variant dynamics identifying wildtype, alpha, delta, and omicron BA.4/5 as key variants in the study population, and cross-immunity between variants, revealing risk reductions between 24% and 69%. An antibody-level model predicts slow decay leading to sustained high antibody levels. Retrospectively, increased early vaccination might have substantially reduced infections during the delta and omicron waves in the considered group of individuals, though further vaccination now seems less impactful.

Identifiants

pubmed: 38658564
doi: 10.1038/s41467-024-47556-2
pii: 10.1038/s41467-024-47556-2
doi:

Substances chimiques

Antibodies, Viral 0
COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3463

Subventions

Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : MoKoCo19; 01KI20271 and FitMultiCell; 031L0159C and INSIDe; 031L0297A
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : ORCHESTRA; 101016167
Organisme : Volkswagen Foundation (VolkswagenStiftung)
ID : E2; 99 450

Informations de copyright

© 2024. The Author(s).

Références

Gudina, E. K. et al. Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities. Lancet Glob. Health 9, e1517–e1527 (2021).
doi: 10.1016/S2214-109X(21)00386-7 pubmed: 34678196 pmcid: 8525918
Mulu, A. et al. The challenges of COVID-19 testing in Africa: the Ethiopian experience. Pan Afr. Med. J. 38, 6 (2021).
doi: 10.11604/pamj.2021.38.6.26902 pubmed: 33520075 pmcid: 7825374
Lamptey, E., Senkyire, E. K., Benita, D. A. & Boakye, E. O. COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production. Clin. Exp. Vaccin. Res. 11, 82–88 (2022).
doi: 10.7774/cevr.2022.11.1.82
Sahile, A. T., Gizaw, G. D., Mgutshini, T., Gebremariam, Z. M. & Bekele, G. E. COVID-19 Vaccine Acceptance Level in Ethiopia: A Systematic Review and Meta-Analysis. Can. J. Infect. Dis. Med. Microbiol. 2022, 2313367 (2022).
doi: 10.1155/2022/2313367 pubmed: 36061634 pmcid: 9436617
Tonen-Wolyec, S., Mbumba Lupaka, D.-M., Batina-Agasa, S., Mbopi Keou, F.-X. & Bélec, L. Review of authorship for COVID-19 research conducted during the 2020 first-wave epidemic in Africa reveals emergence of promising African biomedical research and persisting asymmetry of international collaborations. Trop. Med. Int. Health 27, 137–148 (2022).
doi: 10.1111/tmi.13717 pubmed: 34984771
Abagero, A. et al. A Review of COVID-19 Response Challenges in Ethiopia. Int. J. Environ. Res. Public Health 19, 11070 (2022).
doi: 10.3390/ijerph191711070 pubmed: 36078785 pmcid: 9518440
Gelanew, T. et al. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers. BMC Infect. Dis. 22, 261 (2022).
doi: 10.1186/s12879-022-07247-z pubmed: 35296265 pmcid: 8926102
Abdella, S. et al. Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic. EClinicalMedicine 35, 100880 (2021).
doi: 10.1016/j.eclinm.2021.100880 pubmed: 34124630 pmcid: 8176122
Sisay, A. et al. Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022. Genes 14, 705 (2023).
doi: 10.3390/genes14030705 pubmed: 36980977 pmcid: 10047986
Olbrich, L. et al. Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2. J. Gen. Virol. 102, 001653 (2021).
doi: 10.1099/jgv.0.001653 pubmed: 34623233 pmcid: 8604188
Le Gleut, R. et al. The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant. BMC Infect. Dis. 23, 1–15 (2023).
doi: 10.1186/s12879-023-08435-1
Gangavarapu, K. et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat. Methods 20, 512–522 (2023).
Tsueng, G. et al. Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resources. Nat. Methods 20, 536–540 (2023).
doi: 10.1038/s41592-023-01770-w pubmed: 36823331 pmcid: 10393269
Mohammadi-Kambs, M., Hölz, K., Somoza, M. M. & Ott, A. Hamming Distance as a Concept in DNA Molecular Recognition. ACS Omega 2, 1302–1308 (2017).
doi: 10.1021/acsomega.7b00053 pubmed: 28474009 pmcid: 5410656
Kindhi, B. A., Hendrawan, M. A., Purwitasari, D., Sardjono, T. A. & Purnomo, M. H. Distance-based pattern matching of DNA sequences for evaluating primary mutation. in 2017 2nd International conferences on Information Technology, Information Systems and Electrical Engineering (ICITISEE) 310–314. https://doi.org/10.1109/ICITISEE.2017.8285518 (2017).
Chen, Z., Bancej, C., Lee, L. & Champredon, D. Antigenic drift and epidemiological severity of seasonal influenza in Canada. Sci. Rep. 12, 15625 (2022).
doi: 10.1038/s41598-022-19996-7 pubmed: 36115880 pmcid: 9482630
Ethiopia launches a COVID-19 vaccination campaign targeting the 12 years and above population. WHO | Regional Office for Africa https://www.afro.who.int/news/ethiopia-launches-covid-19-vaccination-campaign-targeting-12-years-and-above-population .
Ma, K. C. et al. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years − 18 U.S. Jurisdictions, September 2021-December 2022. MMWR Morb. Mortal. Wkly. Rep. 72, 683–689 (2023).
doi: 10.15585/mmwr.mm7225a3 pubmed: 37347715 pmcid: 10328471
Habenom, H., Aychluh, M., Suthar, D. L., Al-Mdallal, Q. & Purohit, S. D. Modeling and analysis on the transmission of covid-19 Pandemic in Ethiopia. Alex. Eng. J. 61, 5323–5342 (2022).
doi: 10.1016/j.aej.2021.10.054
Nkwayep, C. H., Bowong, S., Tsanou, B., Alaoui, M. A. A. & Kurths, J. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon. Math. Med. Biol. 39, 1–48 (2022).
doi: 10.1093/imammb/dqab020 pubmed: 35045180
Akuka, P. N. A., Seidu, B. & Bornaa, C. S. Mathematical Analysis of COVID-19 Transmission Dynamics Model in Ghana with Double-Dose Vaccination and Quarantine. Comput. Math. Methods Med. 2022, 7493087 (2022).
doi: 10.1155/2022/7493087 pubmed: 35928979 pmcid: 9344484
Khan, M. A. & Atangana, A. Mathematical modeling and analysis of COVID-19: A study of new variant Omicron. Phys. A 599, 127452 (2022).
doi: 10.1016/j.physa.2022.127452
Li, X.-P. et al. Assessing the potential impact of COVID-19 Omicron variant: Insight through a fractional piecewise model. Results Phys. 38, 105652 (2022).
doi: 10.1016/j.rinp.2022.105652 pubmed: 35663799 pmcid: 9150900
Wangari, I. M. et al. Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism. Comput. Math. Methods Med. 2021, 5384481 (2021).
doi: 10.1155/2021/5384481 pubmed: 34777563 pmcid: 8578696
Oke, A. S., Bada, O. I., Rasaq, G. & Adodo, V. Mathematical analysis of the dynamics of COVID-19 in Africa under the influence of asymptomatic cases and re-infection. Math. Methods Appl. Sci. 45, 137–149 (2022).
doi: 10.1002/mma.7769 pubmed: 34908633
Stein, C. et al. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet 401, 833–842 (2023).
doi: 10.1016/S0140-6736(22)02465-5
Altarawneh, H. N. et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N. Engl. J. Med. 386, 1288–1290 (2022).
doi: 10.1056/NEJMc2200133 pubmed: 35139269
Van Elslande, J. et al. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection. Diagn. Microbiol. Infect. Dis. 103, 115659 (2022).
doi: 10.1016/j.diagmicrobio.2022.115659 pubmed: 35278794 pmcid: 8837483
Iversen, K. et al. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin. Microbiol. Infect. 28, 710–717 (2022).
doi: 10.1016/j.cmi.2021.09.005 pubmed: 34543759
Quick, J. nCoV-2019 sequencing protocol v2 (GunIt) v2 https://doi.org/10.17504/protocols.io.bdp7i5rn (2020).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv [q-bio.GN] (2013).
Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).
doi: 10.1186/s13059-018-1618-7 pubmed: 30621750 pmcid: 6325816
O’Toole, Á. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 7, veab064 (2021).
doi: 10.1093/ve/veab064 pubmed: 34527285 pmcid: 8344591
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
doi: 10.1093/bioinformatics/bty407 pubmed: 29790939 pmcid: 6247931
Raimúndez, E. et al. COVID-19 outbreak in Wuhan demonstrates the limitations of publicly available case numbers for epidemiological modeling. Epidemics 34, 100439 (2021).
doi: 10.1016/j.epidem.2021.100439 pubmed: 33556763 pmcid: 7845523
Hucka, M. et al. The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 2 Core Release 2. J. Integr. Bioinform. 16, 20190021 (2019).
pubmed: 31219795 pmcid: 6798823
Fröhlich, F. et al. AMICI: high-performance sensitivity analysis for large ordinary differential equation models. Bioinformatics 37, 3676–3677 (2021).
doi: 10.1093/bioinformatics/btab227 pubmed: 33821950 pmcid: 8545331
Schälte, Y. et al. pyPESTO: A modular and scalable tool for parameter estimation for dynamic models. Bioinformatics 39, btad711 (2023).
Schmiester, L. et al. PEtab-Interoperable specification of parameter estimation problems in systems biology. PLoS Comput. Biol. 17, e1008646 (2021).
doi: 10.1371/journal.pcbi.1008646 pubmed: 33497393 pmcid: 7864467
Leinonen, R., Sugawara, H. & Shumway, M., International Nucleotide Sequence Database Collaboration. The sequence read archive. Nucleic Acids Res 39, D19–D21 (2011).
doi: 10.1093/nar/gkq1019 pubmed: 21062823

Auteurs

Simon Merkt (S)

Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany.

Solomon Ali (S)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Esayas Kebede Gudina (EK)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Wondimagegn Adissu (W)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Addisu Gize (A)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
CIH LMU Center for International Health, LMU Munich, Munich, Germany.

Maximilian Muenchhoff (M)

Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU Munich, Munich, Germany.
German Center for Infection Research (DZIF), partner site Munich, Munich, Germany.

Alexander Graf (A)

Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Munich, Germany.

Stefan Krebs (S)

Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Munich, Germany.

Kira Elsbernd (K)

Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany.

Rebecca Kisch (R)

Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Sisay Sirgu Betizazu (SS)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Bereket Fantahun (B)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Delayehu Bekele (D)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Raquel Rubio-Acero (R)

Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Mulatu Gashaw (M)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Eyob Girma (E)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Daniel Yilma (D)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Ahmed Zeynudin (A)

Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia.

Ivana Paunovic (I)

Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany.

Michael Hoelscher (M)

German Center for Infection Research (DZIF), partner site Munich, Munich, Germany.
Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany.
Unit Global Health, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

Helmut Blum (H)

Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Munich, Germany.

Jan Hasenauer (J)

Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. jan.hasenauer@uni-bonn.de.
Institute of Computational Biology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany. jan.hasenauer@uni-bonn.de.
Center for Mathematics, Technische Universität München, Garching, Germany. jan.hasenauer@uni-bonn.de.

Arne Kroidl (A)

German Center for Infection Research (DZIF), partner site Munich, Munich, Germany. akroidl@lrz.uni-muenchen.de.
Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany. akroidl@lrz.uni-muenchen.de.

Andreas Wieser (A)

German Center for Infection Research (DZIF), partner site Munich, Munich, Germany. andreas.wieser@lmu.de.
Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany. andreas.wieser@lmu.de.
Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany. andreas.wieser@lmu.de.
Faculty of Medicine, Max Von Pettenkofer Institute, LMU Munich, Munich, Germany. andreas.wieser@lmu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH